gamma-pn3
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 23, 2023 (NCT05667740)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Streptococcus pneumoniaeImmunity, active
Streptococcus pneumoniae immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06562790 | Phase 1 | Aug 26, 2024 | GPN Vaccines |
| NCT05982314 | Phase 1/Phase 2 (Phase 2) | Jul 17, 2023 | GPN Vaccines |
| NCT05667740 | Phase 1 | Jan 23, 2023 | GPN Vaccines, IDT Australia Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GPN Vaccines | For profit | 3 | 3 | 2 | 2023 |
| IDT Australia Ltd. | For profit | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1